バイオテクノロジーイノベーター

Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy

Teladoc Health to acquire Catapult Health in $65M all-cash deal

Inari Medical ticks higher after HSR waiting period expires in Stryker deal

Sage Therapeutics rejects Biogen bid, starts strategic review

@Investingcom

1月 19, 2025

🎉IT’S A BIG WEEK OF Q4 EARNINGS! 💰 $NFLX $JNJ $PG $VZ $UAL $AAL $GE $MMM $GEV $AXP $TXN $ISRG ARE ALL SET TO DELIVER RESULTS! 📈PLAN EARLY WITH INVESTING PRO WITH ALL KEY DATA IN 1 PLACE: https://t.co/Zh3sZIRv6K 👈 $SPY $QQQ https://t.co/bxOCgp88Fk https://t.co/xO7PzqHpiy

Sage sues Biogen in wake of $469M buyout offer: report

Penumbra spikes after Stryker- Inari deal

Stryker confirms deal to purchase Inari Medical for $80 a share